1,544 results on '"Krueger, James G."'
Search Results
2. Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy
3. Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa
4. The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
5. Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa
6. Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1
7. Genomic Profiling of the Overlap Phenotype between Psoriasis and Atopic Dermatitis
8. Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets.
9. The erythema Q-score, an imaging biomarker for redness in skin inflammation.
10. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis
11. The interferon-rich skin environment regulates Langerhans cell ADAM17 to promote photosensitivity in lupus
12. NFI transcription factors provide chromatin access to maintain stem cell identity while preventing unintended lineage fate choices
13. Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study
14. Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis
15. Gram‐negative anaerobes elicit a robust keratinocytes immune response with potential insights into HS pathogenesis
16. IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy
17. Targeted review of IL36RN mutations in patients with generalised pustular psoriasis
18. A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis
19. Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment
20. Hyperspectral imaging in automated digital dermoscopy screening for melanoma
21. Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
22. Deep resolution of clinical, cellular and transcriptomic inflammatory markers of psoriasis over 52 weeks of interleukin-17A inhibition by secukinumab.
23. Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies.
24. Eosinophils in hidradenitis suppurativa patients exhibit pro‐inflammatory traits, implicating a potential pathogenic role in the disease.
25. Deep resolution of clinical, cellular, and transcriptomic inflammatory markers during 52 weeks of IL-17A inhibition by secukinumab
26. Immune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients
27. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis
28. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes
29. The aging skin microenvironment dictates stem cell behavior
30. Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week
31. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation
32. Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling.
33. Quantifying the natural variation in lesion counts over time in untreated hidradenitis suppurativa: Implications for outcome measures and trial design
34. A Preliminary 18F-FDG-PET/MRI Study Shows Increased Vascular Inflammation in Moderate-to-Severe Atopic Dermatitis
35. Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis
36. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis
37. Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy
38. Early Quantification of Systemic Inflammatory Proteins Predicts Long-Term Treatment Response to Tofacitinib and Etanercept
39. Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis
40. Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood
41. Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.
42. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
43. Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two Phase 3 studies
44. Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
45. Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin
46. Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis
47. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
48. Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis
49. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis
50. Interleukin-17 Inhibition for the Treatment of Inflammatory Skin Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.